Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Cell culture system hailed as 'transforming cultivation'

21-Nov-2006 - Integra Biosciences is hailing its novel cell culture system as being responsible for dramatically transforming the effectiveness of small-scale antibody production.

GSK contract to supply US with bird flu vaccines

21-Nov-2006 - Drug giant GlaxoSmithKline (GSK) has been awarded a contract with the US government to supply 800,000 doses of flu vaccine to the US, where a bird flu pandemic still remains a threat.

New cost-cutting polymers invented

20-Nov-2006 - General Electric (GE) has launched a range of ultra-high-performance plastics that it claims will answer the need for cost-effective injection moldable resin.

Pseudomonas-based protein expression to rival E. coli?

08-Nov-2006 - Drug developers are increasingly turning to Pseudomonas-based expression technology for their hard-to-express proteins, according to contract manufacturer Dowpharma.

Vetter keeps on expanding lyophilisation services

08-Nov-2006 - Germany's Vetter Pharma-Fertigung has announced its plan to expand its services by adding vial filling for lyophilised - or freeze-dried - products to its portfolio.

Diosynth bags cardiovascular drug deal

07-Nov-2006 - Diosynth Biotechnology has bagged a deal for the process development, scale-up, and clinical manufacturing of Viron Therapeutics' lead compound.

Sterile bioreactor sampling system unveiled

06-Nov-2006 - A new method of preventing bioreactor contamination when sampling has been unveiled by UK firm Cellexus Biosystems.

MSD invests €100m in Irish drug making arm

06-Nov-2006 - Merck Sharp & Dohme has just announced a €100m investment in South Tipperary, Ireland to build a new formulation R&D centre and drug manufacturing plant.

Millipore reports profit fall in third quarter

02-Nov-2006 - Massachusetts-based Millipore has reported a fall in net profit in its third quarter results, mainly due to increased costs and recent acquisition charges.

DSM pushes forward with global vision

27-Oct-2006 - A year after it published its five-year strategy: Vision 2010 - Building on Strengths - DSM's commitment is showing no sign of slowing as is continues to invest in the expansion of its pharmaceutical production capabilities around the globe.

Cambrex strips itself to the core with sale of major units

26-Oct-2006 - Cambrex has stripped itself to the core after selling two of its three business units and two further manufacturing facilities this week.

Systech launches packaging automation system

26-Oct-2006 - Systech has launched a new packaging line automation solution that it claims will help drug makers address their manufacturing line inefficiencies.

A world of outsourcing awaits - part III drug manufacturing

25-Oct-2006 - Although manufacturing is the most established of the pharma outsourcing segments, many service areas are still rapidly evolving. OutsourcingPharma.com gives a brief run down of the current state of play.

Continuous coating firm eyes Europe

25-Oct-2006 - O'Hara Technologies chose the recent CPhI in Paris to show off the world's only dedicated continuous coating machine for pharmaceutical tablets.

Bangladesh and The Gambia get in on drug manufacturing

20-Oct-2006 - Two new drug manufacturing facilities have been launched in global areas that don't usually see much pharmaceutical manufacturing activity - Bangladesh and The Gambia.

DSM accelerates anti-infective activity

19-Oct-2006 - Using a processing technique described as "revolutionary," DSM is accelerating its activity in the anti-infective arena and targeting new active pharmaceutical ingredients (APIs) that it can develop into cost-competitive generic versions.

SAFC takes on transgenics and India

18-Oct-2006 - Sigma-Aldrich Group member SAFC made its presence felt at the recent CPhI in Paris with announcements regarding its expansion activities in transgenic manufacturing and India.

Arkema unveils green catalyst

18-Oct-2006 - Arkema has unveiled a new green oxidation catalyst that it claims "makes environmental protection a priority," as well as launching a new product website.

LifeCycle signs three deals for new drug delivery system

17-Oct-2006 - LifeCycle has signed three collaboration agreements with big pharma companies for the development of new anti-cholesterol products using its novel drug delivery technologies.

Pfizer outsources API manufacture to Asia

17-Oct-2006 - Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.

Excelsyn chases process improvement

16-Oct-2006 - Excelsyn Molecular Development claims to have made a "major advance" in a protein intensification process that can be used to slash the manufacturing costs of a range of amino acids.

Sandoz wades deeper into generic biopharmaceuticals

16-Oct-2006 - As it looks to the "future of pharmaceuticals," Sandoz is planning a "powerful biopharmaceuticals programme" with the construction of a new biopharmaceuticals development centre in Ljubljana, Slovenia.

Pall to expand biopharma manufacturing in Puerto Rico

12-Oct-2006 - Filter maker Pall Corporation has announced its plan to invest about $50m (€63.5m) to expand its life sciences manufacturing operations in Puerto Rico and take advantage the island's low tax regime.

Codexis weighs into generics biz via India

12-Oct-2006 - Codexis is using India as a springboard to launch it into direct sales of high-value generic pharmaceutical intermediates, to be sold into unregulated markets for use in patented drugs.

Rhodia provides process and handling updates

12-Oct-2006 - Rhodia was present at this year's CPhI, alerting the industry to its latest product updates, spawned out of the market demand to provide products that allow its customers to better address process and handling requirements.

Sign up for your free newsletter